StockData
bioAffinity Technologies, Inc. logo

bioAffinity Technologies, Inc. (BIAF) stock

BIAFNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31Also trades as BIAFW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/3071% below fair value
$1.93−0.07 (-3.50%)

Close on Nov 17, 2026Market cap $15.64MP/E –Yield –

bioAffinity Technologies operating margin

Operating margin is operating income as a percentage of revenue.

bioAffinity Technologies's operating margin for the twelve months ending Jun 30, 2026 was -209.8%. For fiscal 2025 it was -171.6%, against -95.6% the year before.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-171.6%−75.9
FY2024Dec 31, 2024-95.6%+219.2
FY2023Dec 31, 2023-314.8%−256.7
FY2022Dec 31, 2022-58.1%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-220.8%−22.6
Q1 FY2026Mar 31, 2026-267.6%−125.9
Q4 FY2025Dec 31, 2025-196.9%−63.5
Q3 FY2025Sep 30, 2025-158.6%−74.6
Q2 FY2025Jun 30, 2025-198.2%−111.1
Q1 FY2025Mar 31, 2025-141.7%−60.9
Q4 FY2024Dec 31, 2024-133.5%−29.9
Q3 FY2024Sep 30, 2024-84.0%+684.7
Q2 FY2024Jun 30, 2024-87.1%+8922.7
Q1 FY2024Mar 31, 2024-80.8%+5.4
Q4 FY2023Dec 31, 2023-103.6%−80.1
Q3 FY2023Sep 30, 2023-768.7%+84114.4
Q2 FY2023Jun 30, 2023-9009.8%+43373.0
Q1 FY2023Mar 31, 2023-86.3%–
Q4 FY2022Dec 31, 2022-23.5%–
Q3 FY2022Sep 30, 2022-84883.1%–
Q2 FY2022Jun 30, 2022-52382.8%–

More bioAffinity Technologies figures

See a number that looks wrong?